NeoCore Technology Co., Ltd. (TPEX:4131)
Taiwan · Delayed Price · Currency is TWD 31.20
+0.50 (1.63%)
Oct 8, 2026, 1:30 PM CST
NeoCore Technology Market Cap
NeoCore Technology has a market cap or net worth of 1.24 billion as of October 9, 2026. It is the 32,222nd most valuable company in the world and the 1,934th biggest in Taiwan. Its market cap has decreased by 4.60% in one year.
Market Cap
1.24B
Enterprise Value
1.37B
Revenue
277.54M
Global Rank
Country Rank
#1,934 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2004, NeoCore Technology's market cap has increased from 15.79M to 1.24B, an increase of 7,773.01%. That is a compound annual growth rate of 22.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.24B | -25.04% |
| Dec 31, 2025 | 1.66B | 31.25% |
| Dec 31, 2024 | 1.26B | 45.45% |
| Dec 29, 2023 | 869.00M | 123.11% |
| Dec 26, 2022 | 389.50M | 24.09% |
| Dec 28, 2021 | 313.90M | 1.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.47B |
| GenMont Biotech Incorporation | 1.43B |
| Abnova (Taiwan) | 1.31B |
| Holy Stone Healthcare | 1.24B |
| Bio Preventive Medicine | 1.16B |
| LabTurbo Biotech | 1.11B |
| Enimmune | 1.06B |
| BiOptic | 1.03B |